MPN Hub
A resource for expert-driven education on myeloproliferative neoplasms.
X
X
LinkedIn
LinkedIn
Facebook
Facebook
YouTube
YouTube
Spotify
Spotify
Email
Email
The MPN Hub
The MPN Hub
ASH 2025 | Top abstracts: What’s hot in MPN?
ASH 2025 | Top abstracts: What’s hot in MPN?
The MPN Hub Steering Committee have provided recommendations for the top abstracts to look out for in MPN at the 67th ASH Annual Meeting and Exposition.
Expert Opinion Videos
Expert Opinion Videos
The MPN Hub is an open-access online resource, dedicated to providing healthcare professionals with balanced, credible, and up-to-date medical education in MPN. Our aim is to enhance knowledge in MPN, through the multichannel dissemination of global advances related to their classification, diagnosis, treatment, and management. The MPN Hub shares new data, evidence-based articles, therapy approvals, expert opinions, and international congress coverage to treatment teams and researchers around the world. The MPN Hub is an independent medical education platform, sponsored by pharmaceutical companies; a full list of our supporters can be found on our website mpn-hub.com. The funders are allowed no direct influence on our content.
Podcast (Spotify)
Podcast (Spotify)
Podcast · Scientific Education Support · The MPN Hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education in MPN. Our aim is to enhance knowledge in MPN, through the multichannel dissemination of global advances related to their classification, diagnosis, treatment, and management. Hosted on Acast. See acast.com/privacy for more information.
About Us
About Us
in partnership with the European LeukemiaNet (ELN).
Steering Committee
Steering Committee
in partnership with the European LeukemiaNet (ELN).
Subscribe to the Newsletter
Subscribe to the Newsletter
in partnership with the European LeukemiaNet (ELN).
Contact Us
Contact Us
in partnership with the European LeukemiaNet (ELN).
Brought to you by SES
Brought to you by SES
Discover how SES enhances clinical practice through streamlined, independent medical education, supported by leading healthcare experts and societies.
In partnership with European LeukemiaNet (ELN)
In partnership with European LeukemiaNet (ELN)
Ca. 220 participating centers in 45 countries with more than 1000 researchers and clinicians are cooperating in the European LeukemiaNet. The objective is to integrate the about 120 leading leukemia trial groups (CML, AML, ALL, CLL, MDS, MPN), their interdisciplinary partner groups (diagnostics, treatment research), industry and SMEs to form an international network promoting cooperative research for curing leukemia. Important instrument are regular meetings, common projects and uniform definitions through management recommendations for each type of leukemia and interdisciplinary speciality.
View on mobile
